Investing in Geroscience: A New Frontier in Biotech Capital for Longevity Innovation
2:00 pm - Thursday 29th January 2026
- Exploring investor appetite for longevity-focused startups and clinical programs
- Defining inflection points from IND filing to proof-of-mechanism readouts to guide investment timing
- Highlighting de-risking strategies through biomarkers, partnerships, and AI platforms to improve predictability
